Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Global Integration Team Maps Out Strategies For Planet-wide Alliance Between Pfizer And Wyeth; Cuts Likely In The West, Matched By Expansion In China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - As a global integration team crafts the contours of the pharmaceutical world's first megamerger of 2009, it is also mapping out strategies on how to create the strongest alliance possible between Pfizer and Wyeth while cutting $4 billion in costs and personnel by 2012

You may also be interested in...



Merck, Schering-Plough Aim To Be Among Top-Five Players In Emerging Markets

SHANGHAI - Merck expects to bring more than $2 billion in annual revenue from emerging markets and to meet its goal of reaching the top-five market share in targeted emerging markets following its merger with Schering-Plough

Merck, Schering-Plough Aim To Be Among Top-Five Players In Emerging Markets

SHANGHAI - Merck expects to bring more than $2 billion in annual revenue from emerging markets and to meet its goal of reaching the top-five market share in targeted emerging markets following its merger with Schering-Plough

Pfizer Increasing Size of China R&D Center, Expanding Virtual Research Network Through Alliances With Chinese Scientists, WuXi PharmaTech

BEIJING - Pfizer is set to ramp up its research and development center in Shanghai and to integrate more Chinese scientists into its worldwide virtual R&D network, including a new research deal with Wuxi PharmaTech, according to senior Pfizer executives in Shanghai and Hong Kong

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel